Hiv-associated Tuberculosis
📧 Sign up to get email alerts when something new happens for Hiv-associated Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-20Clinical Trial Results: Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis [Phase 2]
Phase 2 trial evaluating pharmacokinetics and safety of a double-dose dolutegravir regimen when co-administered with rifapentine for HIV-ass…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis [Phase 2]
Phase 2 trial assessing pharmacokinetics and safety of a double-dose dolutegravir regimen when used with rifapentine for HIV-associated tube…